Trials / Unknown
UnknownNCT00370370
Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Shahid Beheshti University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
To compare the efficacy and safety results of intravitreal bevacizumab alone with bevacizumab + triamcinolone acetonide in neovascular AMD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bevacizumab | Injection of intravitreal bevacizumab |
| DRUG | bevacizumab + triamcinolone acetonide | Injection of bevacizumab + triamcinolone acetonide |
Timeline
- Start date
- 2005-11-01
- First posted
- 2006-08-31
- Last updated
- 2008-06-26
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00370370. Inclusion in this directory is not an endorsement.